PharmaDerm
Pioneering new treatments for skin disorders, chronic wounds, severe burns, and dermatology since 2008.
Pioneering new treatments for skin disorders, chronic wounds, severe burns, and dermatology since 2008.
PharmaDerm is a pioneering biotech startup that has been dedicated to developing innovative treatments for skin disorders, chronic wounds, severe burns, and dermatology since 2008. The company specializes in the licensing, development, and commercialization of pharmaceutical and biotech innovations from ICBS Ltd., McCoy Enterprises LLC, and Connell Associates LLC. PharmaDerm LLC has set its sights on bringing new and impactful treatments to the market, addressing critical medical needs in the biotechnology industry. With its headquarters based in the United States, PharmaDerm LLC has positioned itself as a key player in the biotechnology sector, aiming to drive meaningful advancements in healthcare.
There is no investment information
No recent news or press coverage available for PharmaDerm.
We care about your data, and we'd love to use cookies make your experience better.
